ReviewThe oncologist2019

Strategies for Recognizing and Managing Immune-Mediated Adverse Events in the Treatment of Hodgkin Lymphoma with Checkpoint Inhibitors.

Santosha Vardhana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.